Replimune Correlations

REPL Stock  USD 7.03  0.36  4.87%   
The current 90-days correlation between Replimune Group and Ginkgo Bioworks Holdings is 0.24 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Replimune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Replimune Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Replimune Correlation With Market

Very good diversification

The correlation between Replimune Group and DJI is -0.44 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

Moving together with Replimune Stock

  0.62EVAX Evaxion Biotech ASPairCorr
  0.74MYGN Myriad GeneticsPairCorr
  0.65ALNY Alnylam PharmaceuticalsPairCorr
  0.65ATNM Actinium PharmaceuticalsPairCorr
  0.73BCAB BioatlaPairCorr

Moving against Replimune Stock

  0.79HOOK Hookipa PharmaPairCorr
  0.78IPSC Century TherapeuticsPairCorr
  0.69IVA Inventiva SaPairCorr
  0.65MAIA MAIA BiotechnologyPairCorr
  0.62FHTX Foghorn TherapeuticsPairCorr
  0.55GILD Gilead SciencesPairCorr
  0.52INCY IncytePairCorr
  0.39AVH Avita MedicalPairCorr
  0.35GMAB Genmab ASPairCorr
  0.76AEON AEON BiopharmaPairCorr
  0.74CNB0 FORTRESS BIOTECHPRFAPairCorr
  0.722UA BioNTech SEPairCorr
  0.43PCVX VaxcytePairCorr
  0.41ALLO Allogene Therapeutics Buyout TrendPairCorr
  0.35BTC BTC HealthPairCorr
  0.33AMGN Amgen Inc Earnings Call TodayPairCorr
  0.73DAWN Day One BiopharmaceuPairCorr
  0.72LIN Linde plc Ordinary Earnings Call This WeekPairCorr
  0.69PBMRF PT Bumi ResourcesPairCorr
  0.61CAT CaterpillarPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PRMEDNA
ARVNAVBP
ARVNMBX
VIRAVBP
ARVNVIR
AVBPMBX
  

High negative correlations

MGTXMBX
IOVADNA
ARVNDNA
ATXSMGTX
ATXSDNA
MGTXIOVA

Risk-Adjusted Indicators

There is a big difference between Replimune Stock performing well and Replimune Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Replimune's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
DNA  3.39 (0.58) 0.00 (0.22) 0.00 
 8.16 
 28.96 
MBX  4.51  1.32  0.27 (2.71) 3.86 
 14.40 
 29.11 
IOVA  4.27  0.31  0.06  1.94  4.24 
 11.81 
 37.34 
AVBP  3.02  0.25  0.07  0.36  3.17 
 6.71 
 18.12 
MGTX  2.55 (0.25) 0.00 (0.11) 0.00 
 5.08 
 14.00 
PRME  4.64 (0.34) 0.00 (0.23) 0.00 
 12.57 
 23.00 
VALN  2.22 (0.01) 0.00  0.02  2.37 
 4.83 
 15.59 
VIR  3.45  0.31  0.08  0.21  3.78 
 8.08 
 20.46 
ARVN  3.02  0.57  0.15  6.33  3.13 
 5.91 
 28.90 
ATXS  0.85  0.07  0.03 (0.65) 1.00 
 2.11 
 6.54 

Replimune Corporate Management

Colin LoveChief OfficerProfile
Christopher SarchiChief OfficerProfile
Carolyn TrottSenior AssuranceProfile
Pamela EspositoChief Business OfficerProfile
Paul BullockChief HeadProfile
Kari JeschkeSenior AffairsProfile